Application of Signal Regulatory Protein α (shsp-1) Gene in Myocardial Infarction
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 武汉惠康基因科技有限公司
- Publication Date
- 2015-10-28
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of gene function and application, in particular to the function and application of a signal regulatory protein (SIRPα, SHPS-1) in coronary atherosclerotic heart disease. Background technique
[0002] Cardiovascular disease is the disease that causes the highest death rate in the world and is the number one killer of human health. Ischemic heart disease is the leading cause of cardiovascular death. Coronary atherosclerotic heart disease is a disease in which a large amount of lipid deposits on the inner wall of the coronary arteries supplying the myocardium, forming plaques and thrombi that narrow or block the coronary arteries, causing myocardial ischemia, hypoxia or necrosis. Myocardial infarction (MI) is a common type of ischemic heart disease. The coronary artery is occluded and the blood flow is interrupted, resulting in partial necrosis of some myocardium due to severe and persistent ischemia. Within a few minu...